(Q71769449)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

M Ripamonti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L Capolongo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G Melegaro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

C Gornati

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Bargiotti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M Caruso

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M Grandi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Suarato

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

139-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00210784

21 October 2019

exact match

0 references

cites work

Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines

1 reference

12 December 2020

Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR

1 reference

12 December 2020

9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance

1 reference

12 December 2020

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells

1 reference

12 December 2020

MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.

1 reference

12 December 2020

Comparative cytotoxicities of various morpholinyl anthracyclines.

1 reference

12 December 2020

Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.

1 reference

12 December 2020

L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives

1 reference

12 December 2020

Association of DNA cross-linking with potentiation of the morpholino derivative of doxorubicin by human liver microsomes

1 reference

12 December 2020

Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin

1 reference

12 December 2020

In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

1 reference

12 December 2020

Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line

1 reference

12 December 2020

Novel anthracycline analogs

1 reference

12 December 2020

Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.

1 reference

12 December 2020

Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00210784

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8913834%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference